Munich, Germany
January 22 - January 23, 2010
This Symposium is the second in the series of Continuing Medical Education activities organized by Serono Symposia International Foundation for the European Phenylketonuria Group (EPG). Present and future efforts on phenylketonuria (PKU) treatment will be discussed in this event particularly with regard to new pharmacological approaches, such as enzyme substitution and cofactor administration. The importance of patient management will also be highlighted, both in PKU as well as in tetrahydrobiopterin deficient patients. Furthermore, the workshop sessions will offer the possibility to discuss knowledge and experiences on six major aspects of PKU management. The final aim of this Symposium is the improvement of patient management based on sharing the most updated knowledge.
LEARNING OBJECTIVES
After attending this symposium, the participants will have an updated knowledge on:
- Molecular genetics of PKU
- PKU in adult life
- Diagnosis and follow-up of tetrahydrobiopterin deficiencies
- Neuropsychiatric evaluation of PKU patients
- Assessment of quality of life in PKU
- Mechanisms, diagnosis and management of tetrahydrobiopterinresponsiveness in PKU
- Importance of MRS in the treatment of PKU
- Management of mild hyperphenylalaninemia
- Clinical trials with the phenylalanine ammonia lyase (PAL) enzyme substitution therapy
- Nutritional follow-up of PKU patients
TARGET AUDIENCE
Specialists in pediatric and adulthood inherited metabolic diseases, dieticians, nutritionists, clinical biochemists, experts in genetics, basic scientists, and professionals within the area of public health will benefit from this Symposium.
Serono Symposia International Foundation (www.seronosymposia.org) will submit this program “2nd EPG Symposium - Advances and Challenges in PKU” (Munich, Germany - January 22-23, 2010) for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME), the Royal College of Physicians and the Italian Ministry of Health.
